cope
nvest
🇪🇸
Exelixis, Inc.
EXEL
· Healthcare
$56.89
Capitalización: 14.1B USD
Rendimiento por dividendo: —
Advance
¿Es buen momento para comprar Exelixis, Inc.? Pregunta a Copenvest AI
Obtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.
Preguntar a Copenvest AI
→
Cargando gráfico…
Noticias
Últimos titulares de esta acción
Investor's Business Daily
5 sept 2026, 12:00
ServiceNow Leads Five Stocks To Watch Near Buy Points
Investor's Business Daily
4 sept 2026, 16:55
IBD Stock Of The Day Exelixis Hits Earnings Snag — And Then Breaks Out
Zacks
4 sept 2026, 15:30
Exelixis (EXEL) Up 13.3% Since Last Earnings Report: Can It Continue?
GlobeNewswire
3 sept 2026, 13:10
The Global Sustainable Composites Market 2027-2037 Now Available — Reveals Why the Industry's Defining Tension Is Baked Into the Material Itself